Globus Medical (GMED) Income from Continuing Operations (2011 - 2026)
Globus Medical's (GMED) quarterly Income from Continuing Operations came in at 124302000.0 in Q1 2026, up 64.72% YoY from 75462000.0 in Q1 2025, and down 11.59% on a QoQ basis from 140594000.0 in Q4 2025.
Globus Medical (GMED) Income from Continuing Operations (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has 16 years of Income from Continuing Operations data on file, last reported at 124302000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 64.72% year-over-year to 124302000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 586708000.0 (up 216.18% YoY) and the FY2025 annual result came in at 537868000.0, up 422.28% from the prior year.
- Income from Continuing Operations eased to 124302000.0 in Q1 2026, from 140594000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 202846000.0 in Q2 2025 to a low of 7159000.0 in Q1 2024.
- A 5-year average of 62107352.94 and a median of 49129000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The widest YoY moves for Income from Continuing Operations: up 5093.99% in 2024, down 114.57% in 2024.
- Tracing GMED's Income from Continuing Operations over 5 years: stood at 27735000.0 in 2022, then slumped by 45.79% to 15034000.0 in 2023, then soared by 76.3% to 26505000.0 in 2024, then soared by 430.44% to 140594000.0 in 2025, then slipped by 11.59% to 124302000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 124302000.0 (Q1 2026), 140594000.0 (Q4 2025), and 118966000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Globus Medical | 11.59 Bn | 10.99 Bn | 548.17 Mn | 151.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 151.57 Mn |
| Mar 31, 2026 | 124.30 Mn |
| Dec 31, 2025 | 140.59 Mn |
| Sep 30, 2025 | 118.97 Mn |
| Jun 30, 2025 | 202.85 Mn |
| Mar 31, 2025 | 75.46 Mn |
| Dec 31, 2024 | 26.51 Mn |
| Sep 30, 2024 | 51.84 Mn |
| Jun 30, 2024 | 31.76 Mn |
| Mar 31, 2024 | -7.16 Mn |
| Dec 31, 2023 | 15.03 Mn |
| Sep 30, 2023 | 998,000.00 |
| Jun 30, 2023 | 57.71 Mn |
| Mar 31, 2023 | 49.13 Mn |
| Dec 31, 2022 | 27.74 Mn |
| Sep 30, 2022 | 47.43 Mn |
| Jun 30, 2022 | 54.59 Mn |
| Mar 31, 2022 | 38.08 Mn |
| Dec 31, 2021 | -169.71 Mn |
| Sep 30, 2021 | 47.21 Mn |